Scientific Program
| Time | Room A [English] |
|---|---|
| 07:30-08:20 | Registration |
| 08:20-08:30 | Opening Remark and Course Objective |
| 08:30-09:50 | New Concepts in VHD in 2026 I |
| 08:30-08:43 | What's New in Current Guideline in Valvular Heart Disease? Clinical Implication |
| 08:43-08:56 | Multimodality Imaging in Valvular Disease: What Has Changed in the Last Years? |
| 08:56-09:09 | Artificial Intelligence in Valvular Imaging: Hype or Clinical Reality? |
| 09:09-09:22 | Risk Stratification of VHD: Malignant/Arrhythmic MVP or Pitfalls in the Diagnosis of MR Severity |
| 09:22-09:35 | What's Changed in Mitral Valve Recommendations: AFMR/HFpEF Associated MR and Exercise Induced MR |
| 09:35-09:50 | Panel Discussion |
| 09:50-10:10 | Coffee Break |
| 10:10-11:20 | HEART TEAM AT WORK, Learn from Case: Mitral Regurgitation |
| 10:10-10:20 | Patient Presentation and Imaging Analysis |
| 10:20-10:25 | Discussion and Audience Interaction |
| 10:25-10:37 | Assessment: Suitability for TEER: Imager's Point of View |
| 10:37-10:49 | Surgical Treatment of MR: Surgeon's Point of View |
| 10:49-11:01 | Mitral TEER - Device Selection and Planning: Interventionist's Point of View |
| 11:01-11:11 | Heart Team Discussion and Audience Interaction |
| 11:11-11:20 | How Did Our Case End (5 min) |
| 11:20-12:30 | Mitral Regurgitation: Current Strategies for Management and Unresolved Questions |
| 11:20-11:33 | Mitral Valve Imaging for M-TEER: Imaging-Guided Patient Selection |
| 11:33-11:46 | Assessment and Management of MR Recurrence/Persistence after TEER |
| 11:46-11:59 | TEER vs Surgical MV Repair for Functional MR: The State of the Art |
| 11:59-12:12 | What Is Complex Anatomy for Mitral TEER & How I Overcome It? |
| 12:12-12:25 | Beyond TEER: Transcatheter Mitral Valve Replacement and Novel Devices |
| 12:25-12:35 | Panel Discussion |
| 12:35-13:30 | Luncheon Session |
| 12:30-12:50 | Topic 1 |
| 12:50-13:10 | Topic 2 |
| 13:30-13:50 | Opening Ceremony with 10th Anniversary of Echo 360 |
| 13:50-14:40 | Plenary Lectures |
| 13:50-14:10 | Seeing Is Treating: How Imaging Defines Success in Structural Heart Intervention |
| 14:10-14:30 | Rheumatic Heart Disease: What We Know About and Future Perspective |
| 14:30-14:40 | Panel Discussion |
| 14:40-15:00 | Coffee Break |
| 15:00-16:20 | From Rheumatic Burden to Modern Challenges: Redefining Valve Disease in Asia |
| 15:00-15:13 | Asian Valve Disease: Distinct Epidemiology and Emerging Complexity |
| 15:13-15:26 | Beyond Mitral Valve Area: New Insights from the MASTER Registry in Rheumatic MS |
| 15:26-15:39 | Role of Echo and CT in Structural Heart Interventions for Mitral Stenosis |
| 15:39-15:52 | Valve Intervention in Asia: Aging, Small Anatomy, and the Need for Tailored Strategies |
| 15:52-16:05 | Surgical Treatment of Valvular Heart Disease in Asia |
| 16:05-16:20 | Panel Discussion |
| 16:20-17:40 | Echo 360 10th Anniversary Session: From Imaging to Intervention |
| 16:20-16:33 | Dynamic Anatomy of the Valve and Cardiac Chamber Using Non-Invasive Imaging Techniques |
| 16:33-16:46 | Mini TEE: Simplifying Procedural Guidance with Less Invasive Echocardiography |
| 16:46-16:59 | 3D ICE: Expanding Intracardiac Imaging for Real-Time Structural Intervention |
| 16:59-17:12 | 4D Flow CMR for Valvular Heart Disease: What Does It Add in Clinical Practice? |
| 17:12-17:25 | Hybrid Fusion Imaging: Integrating Modalities for Precision-Guided Intervention |
| 17:25-17:40 | Panel Discussion |
| 17:40 | Adjourn |
| 17:30-18:30 | Beer Party for Celebration of 10th Anniversary |
| 18:30 | Faculty Dinner |
| Time | Room B [Korea] |
|---|---|
| 07:30-08:20 | Registration |
| 08:20-08:30 | Opening Remark and Course Objective |
| 08:30-09:50 | [B1] All About Valvular Heart Disease: From the Beginning to Future Perspectives |
| 08:30-08:45 | Imaging: The Evolution of Valve Imaging - Where We Started, Where We Stand (ICE, Mini-TEE, 3D Quantification) |
| 08:45-09:00 | Radiology: From CT Scan to Future Perspectives |
| 09:00-09:15 | Intervention: Milestones, Must-Know Devices, and Techniques You Should Know |
| 09:15-09:30 | Surgery: Milestones, Must-Know Prostheses, and Techniques You Should Know |
| 09:30-09:50 | Panel Discussion |
| 09:50-10:10 | Coffee Break |
| 10:10-11:30 | [B2] The Mitral Valve in 360°: Measure, Guide, Judge |
| 10:10-10:25 | Echo Cardiographic Measure, Interpret, and Decide: Are We Getting It Right? |
| 10:25-10:40 | CT and CMR Evaluation in Patients with MR |
| 10:40-10:55 | Timing of Intervention in MR: What Imaging Tells Us |
| 10:55-11:10 | Follow-up of Prosthetic Mitral Valve: What to Look For, What to Do |
| 11:10-11:30 | Panel Discussion |
| 11:30-12:30 | [B3] Special Echo in 360°: Master the Advanced Tools |
| 11:30-11:45 | Dynamic Anatomy of the Valve and Cardiac Chamber Using Non Invasive Imaging Techniques |
| 11:45-12:00 | Stress Echo Mastery: Unmasking Dynamic Valve Severity |
| 12:00-12:15 | ICE in Structural Valve Intervention: Mastering the Intracardiac View |
| 12:15-12:30 | Panel Discussion |
| 12:30-13:30 | Luncheon Session (Sponsored Session) |
| 12:30-12:50 | Topic 1 |
| 12:50-13:10 | Topic 2 |
| 13:30-13:50 | Opening Ceremony with 10th Anniversary of Echo 360 |
| 13:50-14:40 | Plenary Lectures |
| 14:40-15:00 | Coffee Break |
| 15:00-16:20 | [B5] Basic of Basic in M-TEER |
| 15:00-15:15 | Preprocedural Assessment and Patient Selection |
| 15:15-15:30 | Intraprocedural Echo Imaging - Tips and Tricks |
| 15:30-15:45 | Mitral TEER Procedure - Step-by-Step |
| 15:45-16:00 | Complications and Bailout Strategies in Transcatheter Mitral Interventions |
| 16:00-16:20 | Panel Discussion |
| 16:20-17:40 | Too Embarrassed to Ask: The Essential Tools for SHD |
| 16:20-16:35 | Cardiac Hemodynamics: Honestly, It Confuses Me Too |
| 16:35-16:50 | Cardiac CT: Before You Ask the Radiologist |
| 16:50-17:05 | Cardiac PET/SPECT: Do We Know Why We Order It? |
| 17:05-17:20 | Cardiac MR: Should You Trust the Report? |
| 17:20-17:40 | Panel Discussion |
| 17:40 | Adjourn |
| 17:30-18:30 | Beer Party for Celebration of 10th Anniversary |
| 18:30 | Faculty Dinner |
| Time | Room C [Korea] |
|---|---|
| 07:30-08:20 | Registration |
| 08:20-08:30 | Opening Remark and Course Objective |
| 08:30-09:45 | [C1] Artificial Intelligence in Structural and Genetic Heart Disease |
| 08:30-08:45 | From Images to Insights: The Role of AI in Valvular Heart Disease |
| 08:45-09:00 | AI in Variant Interpretation and Polygenic Risk Score: From VUS to Actionable Diagnosis |
| 09:00-09:15 | AI-Enabled ECG: What It Can and Cannot Do |
| 09:15-09:30 | AI Screening for Cardiomyopathies |
| 09:30-09:50 | Panel Discussion |
| 09:50-10:10 | Coffee Break |
| 10:10-11:20 | [C2] Hot Topics in Cardiac Amyloidosis |
| 10:10-10:23 | My Practical Tips for Catching Cardiac Amyloidosis |
| 10:23-10:36 | Reading the Amyloid Heart: What CMR Sees |
| 10:36-10:49 | Treating Amyloidosis: What's Here, What's Next |
| 10:49-11:02 | Genetic Screening of TTR Amyloidosis: International Perspective |
| 11:02-11:20 | Panel Discussion |
| 11:20-12:30 | [C3] Hot Topics in HCM |
| 11:20-11:33 | Cardiac Myosin Inhibitors in Obstructive HCM |
| 11:33-11:46 | Mitral Valve Disease in HCM: SAM, Intrinsic MV Abnormalities |
| 11:46-11:59 | Management of Non-Obstructive HCM: HFpEF Phenotype |
| 11:59-12:12 | Atrial Fibrillation in HCM: Anticoagulation & Rhythm Control |
| 12:12-12:30 | Panel Discussion |
| 12:30-13:30 | [C3] Luncheon Session (이수앱지스) |
| 12:30-12:50 | Topic 1 |
| 12:50-13:10 | Topic 2 |
| 13:30-14:50 | [C4] Inherited Disease |
| 13:30-13:50 | Cardiac Disease Modeling Using Patient-Derived iPSCs |
| 13:50-14:10 | Genetic Aortopathy |
| 14:10-14:30 | Cardiac Manifestations in Adult Patients with Mitochondrial Disease |
| 14:30-14:50 | Panel Discussion |
| 14:50-15:00 | Coffee Break |
| 15:00-16:40 | [C5] Fabry Disease: Education Lecture |
| 15:00-15:20 | Overview of Clinical Features and Management of Fabry Disease |
| 15:20-15:40 | Decoding the GLA Gene VUS: Advanced Molecular Approaches |
| 15:40-16:00 | Biomarker Monitoring in Fabry Patients |
| 16:00-16:20 | Evidence-Based Practice Guidelines in Fabry Disease |
| 16:20-16:40 | Panel Discussion |